Nine more people test positive for COVID-19

Breaking NewsCommunity News
462

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

Edinburg – Nine more people in Hidalgo County tested positive for COVID-19 bringing the total number of people who have tested positive to 377, Hidalgo County Judge Richard F. Cortez said Friday.

No new people were released from isolation so there are a total of 152 active cases. A total of 5,960 tests have now been administered in the county — 244 of those have been public tests and 5,716 have been private laboratories conducting the tests.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Brownsville native Fulfills Childhood Dream to become a Medical Doctor
Next article
Publisher’s Word: We are Lucky to be Citizens of this Great Nation

More Articles

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -